YOURITY Trademark

Trademark Overview


On Monday, January 6, 2025, a trademark application was filed for YOURITY with the United States Patent and Trademark Office. The USPTO has given the YOURITY trademark a serial number of 98939754. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2026. This trademark is owned by Eli Lilly and Company. The YOURITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative co...
yourity

General Information


Serial Number98939754
Word MarkYOURITY
Filing DateMonday, January 6, 2025
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 6, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
US

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
US

Trademark Events


Event DateEvent Description
Monday, January 6, 2025NEW APPLICATION ENTERED
Monday, January 6, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 5, 2025ASSIGNED TO EXAMINER
Wednesday, February 12, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 6, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 6, 2025SOU TEAS EXTENSION RECEIVED
Monday, October 6, 2025SOU EXTENSION 1 FILED
Monday, October 6, 2025SOU EXTENSION 1 GRANTED
Tuesday, October 7, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 8, 2026ABANDONMENT - NO USE STATEMENT FILED
Monday, June 8, 2026ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED